Form D · Other

Puna Bio Corp

San Francisco, CA · CIK 0002060677

Offering snapshot reported Jun 27, 2025 · SEC filing

Reported sold: $20.3M
Investors reported: 20
Minimum accepted: $0
First sale: Mar 5, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$16,805,209 → $20,305,208
Reported investors19 → 20

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 27, 2025	Amendment	$20,305,208	$3,499,999vs Mar 19, 2025	20	SEC filing
Mar 19, 2025	Initial	$16,805,209	No comparison	19	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-541429

Total amount sold includes $13,190,508.52 of new cash and $7,114,700.35 of cancellation of indebtedness

Source: Form D, filed Jun 27, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Carolina Belfiore	Executive
Elisa Violeta Bertini	Director, Executive
Paul Etenberg	Director
Maria Eugenia Farias	Executive
Fred Gruis	Director
Franco Martinez Levis	Director, Executive
Dario Maffei	Director
Laurie Menoud	Director

Issuer details

Industry: Other (See others in industry)

Address:

479 Jessie St.
San Francisco, CA, 94103